Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
130.90    -0.70 (-0.53%)
Bid:
131.30
Ask:
131.60
Spread: 0.30 (0.228%)
Market Cap: £331.03m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Trading Statement

13 May 2020 07:00

RNS Number : 6900M
Marshalls PLC
13 May 2020
 

 

LEI: 213800S21IFC367J5V62

 

 

Trading Update: 13 May 2020

 

Ahead of its Annual General Meeting at 11.00am today, Marshalls plc, the specialist landscape products group, issues a Trading Update and further information on the measures it is taking in response to the COVID-19 outbreak.

 

COVID-19 update

 

Marshalls continues to monitor the impact that COVID-19 is having on the business and the wider industry. Our priority is to ensure the safety and well-being of our employees, suppliers and customers at this time. In line with our sector, we have seen a sharp drop in demand. As previously advised, actions have been, and continue to be, taken to control costs and maintain our cash liquidity. As part of these actions, the Board and Executive management have agreed to a 20 per cent reduction in remuneration. Senior managers in the business have now also agreed a 15 per cent reduction in their remuneration. Additionally, we are utilising the Government's scheme which allows the deferral of tax payments that would normally have been payable in the period to 30 June 2020. We also continue to utilise the furlough arrangements that are in place.

 

We have now taken further steps to restructure the Group's operations. We have entered into consultations with employees across the Group as part of a series of restructuring proposals that cover all parts the business. These proposals include selective site closures, changes in shift patterns and proposed changes to the size of and structure of support functions. There are potentially up to 400 positions representing 15 per cent of Marshalls total workforce, that may be impacted as a result of these proposed changes. We are reopening our plants as demand returns. The nature of the concrete manufacturing process means our facilities have low re-start time and cost requirements. This flexibility and our improved efficiency means that capacity will not be materially reduced by the proposed changes and we will continue to satisfy our customers' requirements.

 

We are taking all appropriate steps to support the long-term interests of the business, its employees and other stakeholders.

 

Bank Facilities

 

Further to the announcement on 14 April 2020, the Group has now signed final agreements with each of NatWest, Lloyds and HSBC for an additional £30 million, 12 month committed revolving credit facility with each, with a 12-month extension option. These additional facilities comprise £90 million and significantly strengthen the Group's headroom. Including these additional facilities, Marshalls now has total bank facilities of £255 million of which £230 million are committed. As at 30 April the Group had net debt of £69 million, on a pre-IFRS 16 basis.

 

In addition, Marshalls plc has been confirmed as being eligible for the Covid Corporate Financing Facility ("CCFF") with an issuer limit of £200 million. We have now completed the processes and documentation to establish a commercial paper programme under this scheme and are able to access the liquidity available to us under this facility.

 

The Board considers that the facilities now available to the Group, both from its enhanced bank facilities and its CCFF commercial paper programme, are sufficient to meet significant downside liquidity scenarios over a prolonged period.

 

Trading performance

 

As a result of the impact of the COVID-19 crisis, sales in the first four months through to 30 April were down 27 per cent at £131 million (2019: £180 million). Sales activity took a steep drop in the last week of March and throughout April. However, In the early part of May we have seen daily levels of activity progressively improve and we are currently at circa 50 per cent of our daily revenues compared to the same period in 2019.

 

Outlook

 

Our operational planning continues to be dynamic and capable of reacting to the changing environment. We are closely monitoring cash flows to ensure that the business is in a strong position for eventual recovery. Our priority is to ensure the health and safety of our employees, and consequently detailed additional safety standards and procedures have been put in place, which are in line with current Government COVID-19 guidance, to allow our sites to operate safely. We will meet the demands of our stakeholders and protect the long term sustainability of the business.

 

The combined effect of the cost reductions, the restructuring programme and the new bank facilities will leave the Group stronger and well placed to meet the current challenges and also well positioned for eventual future opportunities.

 

At this time, it does not remain possible for the Group to provide an accurate assessment of trading for the current year and accordingly all previous market guidance continues to be withdrawn.

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

Enquiries:

Martyn Coffey

Chief Executive

Marshalls plc

+44 (0)1422 314777

Jack Clarke

Group Finance Director

 

Marshalls plc

+44 (0)1422 314777

Andrew Jaques

 

MHP Communications

+44 (0)20 3128 8540

Charlie Barker

 

 

 

 

Note to the Editor:

 

About Marshalls:

 

Established in the late 1880s, Marshalls is the UK's leading manufacturer of superior natural stone and innovative concrete hard landscaping products, supplying the construction, home improvement and landscape markets. Marshalls provides the product ranges, design services, technical expertise, innovative ideas and inspiration to transform gardens, drives and public and commercial landscapes.

 

Marshalls operates its own quarries and manufacturing sites throughout the UK, including a national network of manufacturing and distribution sites, and has operations in Belgium and sales representation in other international markets. As a major plc, Marshalls is committed to quality in everything it does, including the achievement of high environmental and ethical standards and continual improvement in health and safety performance.

 

Forward-Looking Statements:

 

Any statements in this release, to the extent that they are forward-looking, are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the markets in which Marshalls operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. More information about the factors that may affect Marshalls' performance is contained in the Annual Report to shareholders for the year ended 31 December 2019.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTATMFTMTBBBJM
Date   Source Headline
17th Aug 20237:00 amRNSDirector/PDMR Shareholding
16th Aug 20237:00 amRNSHalf-year Report
2nd Aug 20238:49 amRNSHolding(s) in Company
31st Jul 20237:00 amRNSTrading Statement
21st Jul 202311:25 amRNSDirector Declaration
19th Jul 202312:09 pmRNSDirector Declaration
13th Jul 20234:44 pmRNSDirector/PDMR Shareholding
13th Jul 20234:42 pmRNSDirector/PDMR Shareholding
13th Jul 20234:40 pmRNSDirector/PDMR Shareholding
26th Jun 20234:45 pmRNSDirector/PDMR Shareholding
26th Jun 20234:42 pmRNSDirector/PDMR Shareholding
21st Jun 20232:13 pmRNSHolding(s) in Company
25th May 20233:05 pmRNSHolding(s) in Company
12th May 20239:13 amRNSHolding(s) in Company
10th May 20234:48 pmRNSResult of AGM
10th May 202312:53 pmRNSResult of AGM
9th May 20231:06 pmRNSDirector/PDMR Shareholding
9th May 202312:31 pmRNSDirector/PDMR Shareholding
9th May 202310:34 amRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSTrading Statement
4th Apr 20238:57 amRNSAnnual Financial Report
29th Mar 202312:19 pmRNSEBT Share Purchase
20th Mar 20235:25 pmRNSDirector/PDMR Shareholding
17th Mar 20232:00 pmRNSHolding(s) in Company
17th Mar 20231:46 pmRNSDirector/PDMR Shareholding
17th Mar 202311:18 amRNSDirector/PDMR Shareholding
17th Mar 202311:17 amRNSDirector/PDMR Shareholding
17th Mar 20239:08 amRNSDirector/PDMR Shareholding
16th Mar 20232:49 pmRNSDirector/PDMR Shareholding
15th Mar 20232:45 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSFinal Results
10th Mar 20239:04 amRNSHolding(s) in Company
20th Feb 202310:42 amRNSHolding(s) in Company
16th Feb 202311:42 amRNSHolding(s) in Company
6th Feb 202311:23 amRNSHolding(s) in Company
3rd Feb 202312:51 pmRNSHolding(s) in Company
1st Feb 20232:21 pmRNSDirector/PDMR Shareholding
27th Jan 20231:32 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSTrading Statement
13th Jan 20231:55 pmRNSHolding(s) in Company
8th Nov 20222:12 pmRNSDirectorate Change
8th Nov 202212:01 pmRNSHolding(s) in Company
25th Oct 20224:27 pmRNSHolding(s) in Company
7th Oct 20223:36 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSTrading Statement
22nd Sep 20227:00 amRNSCapital Markets Day
19th Aug 20223:36 pmRNSDirector/PDMR Shareholding
18th Aug 20227:00 amRNSHalf-year Report
3rd Aug 20224:12 pmRNSHolding(s) in Company
18th Jul 202210:04 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.